ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 6 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

Groups Lobby Congress For $5.8 Billion Budget For NCI, Increases For Other Programs

June 18, 2010

Proton Beam Radiation Helps Cancer Patients Retain Vision

August 26, 2005

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999